oral immunomodulator
Showing 26 - 50 of >10,000
Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic acid, Low-dose aspirin)
Recruiting
- Hydroxychloroquine
- Hydroxychloroquine
- +3 more
-
Assiut, EgyptAbdel-rahman Mahmoud Mohammed
Jul 21, 2021
Asthma in Children, Asthma Trial (Blood sample, Expectoration, Nasopharyngeal swab)
Not yet recruiting
- Asthma in Children
- Asthma
- Blood sample
- +2 more
- (no location specified)
Sep 18, 2023
COVID-19 Trial in Yogyakarta, Kota Jkt Utara (AD17002 + Formulation buffer, Placebo)
Not yet recruiting
- COVID-19
- AD17002 + Formulation buffer
- Placebo
-
Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia
- +2 more
Sep 13, 2022
Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)
Recruiting
- Glioblastoma Multiforme of Brain
- Multipeptide plus XS15
-
Tübingen, BW, GermanyUniversity Hospital Tübingen
May 9, 2022
Epithelial Ovarian Cancer Trial in Jakarta, Jakarta Pusat (Vitamin D, Placebo)
Recruiting
- Epithelial Ovarian Cancer
- Vitamin D
- Placebo
-
Jakarta, DKI Jakarta, Indonesia
- +2 more
Jun 18, 2022
Coronavirus Disease 2019 (COVID-19) Trial in United States (CD24Fc, Placebo)
Completed
- Coronavirus Disease 2019 (COVID-19)
- CD24Fc
- Placebo
-
Jacksonville, Florida
- +9 more
Oct 13, 2021
Solid Tumor, Adult Trial in Geneva, Zürich (MVX-ONCO-2)
Withdrawn
- Solid Tumor, Adult
- MVX-ONCO-2
-
Geneva, Switzerland
- +1 more
Jan 27, 2023
COVID-19 Trial in Viña Del Mar (MC 3x3, Placebo)
Not yet recruiting
- COVID-19
- MC 3x3
- Placebo
-
Viña Del Mar, Valparaiso, ChileHospital Gustavo Fricke
Jul 18, 2022
Primary Sjögren's Syndrome Painful Sensory Neuropathies Trial in Strasbourg (Privigen® 100mg/ml at the dose of 2g/kg of body
Recruiting
- Primary Sjögren's Syndrome Painful Sensory Neuropathies
- Privigen® 100mg/ml at the dose of 2g/kg of body weight
- NaCl 0,9%
-
Strasbourg, FranceUniversity Hospital, Strasbourg, france
Jul 7, 2022
Crohn Disease Trial in Philadelphia (Vancomycin, Neomycin, Ciprofloxacin)
Completed
- Crohn Disease
- Vancomycin
- +4 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 8, 2022
Knee Osteoarthritis Trial in Çorum (Nigella sativa oil, Naproxen and lidocaine gel, Massage)
Completed
- Knee Osteoarthritis
- Nigella sativa oil
- +2 more
-
Çorum, TurkeyHitit University
Sep 12, 2022
Dysmotility Syndrome, Autoimmunity Trial in Baltimore (Current Intravenous Immunoglobulin (IVIG) treatment, No Intravenous
Recruiting
- Dysmotility Syndrome
- Autoimmunity
- Current Intravenous Immunoglobulin (IVIG) treatment
- No Intravenous Immunoglobulin (IVIG) treatment
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Mar 8, 2022
Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)
Enrolling by invitation
- Interstitial Fibrosis
- +6 more
- Fingolimod
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Jan 23, 2023
Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)
Recruiting
- Cognitive Impairment, Mild
- +4 more
- Lenalidomide 10 mg
- Placebo
-
Phoenix, Arizona
- +1 more
Apr 14, 2022
Lymphoma Trial in United States (Tomivosertib (eFT-508))
Terminated
- Lymphoma
- Tomivosertib (eFT-508)
-
Los Angeles, California
- +9 more
Oct 30, 2020
Pemphigus Vulgaris Trial in Changsha (recombinant human interleukin-2 (rhIL-2), )
Recruiting
- Pemphigus Vulgaris
- recombinant human interleukin-2 (rhIL-2)
- placebo
-
Changsha, Hunan, ChinaThe Second Xiangya Hospital of Central South University
Jan 31, 2021
Primary Progressive Multiple Sclerosis Trial in Worldwide (Placebo, Laquinimod)
Completed
- Primary Progressive Multiple Sclerosis
- Placebo
- Laquinimod
-
Phoenix, Arizona
- +98 more
Mar 9, 2022
Immune Health Trial in Mumbai, Palghar, Thane (Aqueous extract of roots plus leaves of Withania somnifera 125 mg, Aqueous
Completed
- Immune Health
- Aqueous extract of roots plus leaves of Withania somnifera 125 mg
- +2 more
-
Mumbai, Maharashtra, India
- +2 more
Oct 18, 2021
Allergic Rhinitis Trial in Taipei City (AD17002, Formulation Buffer)
Completed
- Allergic Rhinitis
- AD17002
- Formulation Buffer
-
Taipei City, TaiwanTaipei Medical University
Sep 13, 2021
Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of
Recruiting
- Intracerebral Hemorrhage
- +4 more
- Fingolimod 0.5 mg
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 28, 2022
Covid19, Respiratory Disease, Immune System Trial in Plovdiv (Viusid, Asbrip, Standard Care)
Completed
- Covid19
- +5 more
- Viusid
- +2 more
-
Plovdiv, Bulgaria
- +1 more
Oct 20, 2021
Oral Ulceration Due to Behçet's Disease Trial (Rebamipide mouthwash, Betamethasone mouthwash)
Not yet recruiting
- Oral Ulceration Due to Behçet's Disease
- Rebamipide mouthwash
- Betamethasone mouthwash
- (no location specified)
Oct 13, 2023
COVID-19 Pneumonia Trial in Naples (Saisei Maf capsules)
Completed
- COVID-19 Pneumonia
- Saisei Maf capsules
-
Naples, ItalyOspedale del Mare Hospital
Sep 7, 2021
Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)
Recruiting
- Oral Squamous Cell Carcinoma
- Oral Mucositis
- Alfacalcidol Oral Solution
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Aug 24, 2023
Oral Mucositis Trial in Istanbul (coconut oil)
Not yet recruiting
- Oral Mucositis
- coconut oil
-
Istanbul, TurkeyBaşakşehir Çam and Sakura City Hospital
May 8, 2023